2m 2m 2m 2m 2m 2m 2m
IMMUNOCORE SP ADS (IMCR)
NASDAQ
$32.36-$0.13 (-0.41%)
Price as of Jul 14, 2026 5:14 AM EDT- $1.7BMarket Cap
- -7.96%1-Year Change
- BiotechnologyIndustry
IMMUNOCORE SP ADS (IMCR)
$32.36-$0.13 (-0.41%)
IMCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.49 | ||
Change | +$0.54 (+1.69%) | ||
Open | $31.71 | ||
High | $33.28 | ||
Low | $30.29 | ||
Previous Close | $31.95 | ||
Volume | 896,475 | ||
30-Day Average Volume | 698,549 | ||
1-Week Change | 1.72% | ||
1-Month Change | 12.19% | ||
1-Year Change | -7.96% | ||
3-Year Change | -48.06% | ||
5-Year Change | -10.74% | ||
Fundamentals | |||
Shares Outstanding | 50.9M | ||
Total Assets | $1.1B | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $106.7M | ||
Net Income | $13.0M | ||
Free Cash Flow | -$15.6M | ||
EBIT | $16.3M | ||
EBITDA | $17.3M | ||
Net Working Capital | $763.7M | ||
EPS | $0.25 | ||
Enterprise Value/EBITDA | 92 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 4 | ||
P/E | 130 | ||
PEG | 1 | ||
Price/Free Cash Flow | -106 | ||
Price/Operating Cash Flow | -120 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue